Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy

Pedro J. Beltran, Frank J. Calzone, Petia Mitchell, Young Ah Chung, Elaina Cajulis, Gordon Moody, Brian Belmontes, Chi Ming Li, Steven Vonderfecht, Victor E. Velculescu, Guorong Yang, Jingwei Qi, Dennis J. Slamon, Gottfried E. Konecny

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Ganitumab (AMG 479) inhibits IGF-II-dependent ovarian cancer growth and potentiates platinum-based chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences